We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Ejaculation did not increase the risk of pharyngealgonorrhea.
2
To our knowledge, there have been no longitudinal studies in a prospective MSM cohort to estimate pharyngealgonorrhea incidence or predictors of infection.
3
We examined the prevalence, incidence, and sociodemographic and behavioral predictors of pharyngealgonorrhea in a cohort of sexually active, human immunodeficiency virus-negative MSM.
4
Background: The Centers for Disease Control and Prevention guidelines for pharyngealgonorrhea treatment recommend dual therapy with intramuscular ceftriaxone and either azithromycin or doxycycline.
5
Conclusions: In this retrospective study, dual therapy with an oral third-generation cephalosporin and azithromycin was comparable to ceftriaxone-based regimens in the treatment of pharyngealgonorrhea.
6
Results: A total of 1440 cases of pharyngealgonorrhea were diagnosed during the study period, 25% of which (n = 360) underwent retesting.
7
Pharyngealgonorrhea was positively associated with younger age and the number of insertive oral sex partners in the past 3 months.